Moreover, the hyperactivity of the IL-4/STAT6 pathway is associated with asthma and chronic obstructive pulmonary disease, and the transcriptional inhibitors of this pathway are potential targets for the prevention and treatment of diseases caused by the hyperactivity of the IL-4/STAT6 pathway [41, 42]. This evidence concerns the gene STAT6 and chronic obstructive pulmonary disease.